| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±2.0% | -2.2% | under-priced |
| November 5, 2025 | ±1.7% | -0.1% | over-priced |
| August 7, 2025 | ±2.4% | +1.8% | over-priced |
| May 8, 2025 | ±2.0% | -0.1% | over-priced |
| November 6, 2024 | ±2.2% | +7.3% | under-priced |
| August 6, 2024 | ±2.6% | -2.1% | over-priced |
| May 7, 2024 | ±1.3% | +1.8% | under-priced |
| November 3, 2023 | ±2.2% | +0.4% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.58 | $3.4B | $1.1B |
| Q4 FY2025 | $0.54 | $4.6B | $484M |
| Q3 FY2025 | $0.12 | $2.8B | $150M |
| Q2 FY2025 | $0.71 | $2.7B | $519M |
Sempra (SRE) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 2.0% on average — the market has been roughly fair on SRE's earnings risk. Fundamentals into the print: EPS up 13.7% year-over-year, revenue down 6.9%. QuantLogix's live 5-factor engine currently reads SRE as a buy at 60/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →